This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Boryung Pharmaceutical Co., Ltd.. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Cheon-Ik Park: Innovator in Plant Cell Technology
Introduction
Cheon-Ik Park is a notable inventor based in Anyang, South Korea. He has made significant contributions to the field of biotechnology, particularly in the production of target proteins through innovative methods involving plant cells.
Latest Patents
One of his key patents is titled "Method for producing target proteins using amino acids and pyruvic acids in culture of plant cells." This patent outlines a method for producing a target protein via the cultivation of transgenic plant cells. The process utilizes a promoter capable of expressing the protein under sugar-free conditions in response to the depletion of sugar. It also involves a gene encoding the target protein, allowing for production without the need to exchange the cell growth medium with a sugar-depleted medium. Instead, an amino acid mixture is added to the sugar-rich medium used to grow the plant cells. This innovative approach enhances the efficiency of protein production in plant cell cultures.
Career Highlights
Cheon-Ik Park is currently associated with Boryung Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in pharmaceuticals and biotechnology.
Collaborations
He has collaborated with notable colleagues, including Sang-Lin Kim and Hyun-Kwang Tan, who have contributed to his research endeavors.
Conclusion
Cheon-Ik Park's innovative methods in plant cell technology represent a significant advancement in the field of biotechnology. His contributions are paving the way for more efficient production of target proteins, which could have far-reaching implications in various industries.